Quest Diagnostics Reports Second Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- US futures fall on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Quest Diagnostics (DGX) Reports In-Line Q2 EPS, Slight Revenue Miss; Narrows FY18 EPS Outlook, Lowers FY18 Revenue Mid-Point Guidance
July 24, 2018 6:49 AM EDTQuest Diagnostics (NYSE: DGX) reported Q2 EPS of $1.75, in-line with the analyst estimate of $1.75. Revenue for the quarter came in at $1.91 billion versus the consensus estimate of $1.95 billion.
"Once again, we grew revenues and delivered strong earnings growth in the second quarter,\" said... More
